dihexa from science.bio nuBioAge - 30 Capsules Dihexa 1mL(10 mM in DMSO)

Useful for testing a peptide targeting dopaminergic neuroprotection

Energy expenditure (possible): Some evidence amylin may increase energy expenditure Not as strong as mechanism Minor contributor if real Why amylin is effective for obesity Physiologic rationale: Amylin naturally controls meal size Obesity often associated with amylin resistance Type 2 diabetics have reduced amylin Replacing/supplementing amylin restores control Addresses root cause Synergy with insulin: Both co-secreted normally Work together to regulate feeding Amylin prevents overeating Insulin handles glucose Complementary hormones Comparison to GLP-1 mechanisms: GLP-1: Moderate gastric slowing, strong central appetite effects Amylin: Very strong gastric slowing, moderate central effects Different receptor pathways Complementary not redundant Can combine for synergy Get personalized weight loss protocols at SeekPeptides using our peptide calculator and peptide cost calculator

It has shown potential for supporting the management of chronic gastrointestinal conditions, such as inflammatory bowel diseases (IBD), including ulcerative colitis (UC)

Clinical studies of intranasal insulin have shown cognitive improvement and enhanced functional connectivity, indicating beneficial effects on synaptic activity (Ong et al., 2014)

While not as high as the 23% weight loss seen in REDEFINE 1, 16% is still significant